Abstract:Ischemic stroke, as a prevalent neurological disorder, often results in rapid increases in the production of reactive oxygen species (ROS) and inflammatory factors in the focal ischemic area. Though edaravone is an approved treatment, its effect is limited due to its weak ability to cross the blood-brain barrier (BBB) and short half-life. Other effective pharmacological treatment options are clearly lacking. In this study, PNIVDBrF-3-Eda (also named MG-3-Eda) was prepared using a thermo- and pH dual-responsive PNIVDBrF microgel. These were designed with a positively charged network, as synthesized by simultaneous quaternization cross-linking and surfactant-free emulsion copolymerization, to be loaded with the negatively charged edaravone. We then investigated whether such a targeted delivery of edaravone could provide enhanced neuroprotection. Cytotoxicity assays confirmed that the microgel (<1 mg/mL) exhibited promising cytocompatibility with no remarkable effect on cell viability, cell cycle regulation, or apoptosis levels. In vitro and in vivo experiments demonstrated that the microgels could successfully penetrate the blood-brain barrier where efficient BBB crossing was observed after disruption of the BBB due to ischemic injury. This enabled MG-3-Eda to target the cerebral ischemic area and achieve local release of edaravone. Treatment with MG-3-Eda significantly reduced the cerebral infarct area in transient middle cerebral artery occlusion (tMCAO) mice and significantly improved behavioral scores. MG-3-Eda treatment also prevented the reduction in NF200 expression, a neuronal marker protein, and attenuated microglia activation (as detected by Iba1) in the local ischemic area via local antioxidant and anti-inflammatory effects. A superior neuroprotective effect was noted for MG-3-Eda compared to that for free edaravone. Our results indicate that MG-3-Eda administration represents a clear potential treatment for cerebral ischemia via its targeted delivery of edaravone to ischemic areas where it provides significant local antioxidant and anti-inflammatory effects.

A One-Stone-Two-Birds Strategy of Targeting Microbubbles with “Dual” Anti-Inflammatory and Blood–Brain Barrier “Switch” Function for Ischemic Stroke Treatment

Ultrasound Controlled Anti‐Inflammatory Polarization of Platelet Decorated Microglia for Targeted Ischemic Stroke Therapy

Dual-function Hydrogels with Sequential Release of GSK3β Inhibitor and VEGF Inhibit Inflammation and Promote Angiogenesis after Stroke

Targeted Therapy of Ischemic Stroke Via Crossing the Blood-Brain Barrier Using Edaravone-Loaded Multiresponsive Microgels.

Targeted Treatment of Ischemic Stroke by Bioactive Nanoparticle-Derived Reactive Oxygen Species Responsive and Inflammation-Resolving Nanotherapies.

Dual Targeted Nanocarrier for Brain Ischemic Stroke Treatment

Ph-Sensitive, Cerebral Vasculature-Targeting Hydroxyethyl Starch Functionalized Nanoparticles For Improved Angiogenesis And Neurological Function Recovery In Ischemic Stroke

Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke

Targeted Mrna Nanoparticles Ameliorate Blood-Brain Barrier Disruption Postischemic Stroke by Modulating Microglia Polarization

Hybrid stem cell-derived bioresponsive vesicles for effective inflamed blood-brain barrier targeting delivery

Novel multifunctional bionanoparticles modified with sialic acid for stroke treatment

Phosphatidylserine-microbubble Targeting-Activated Microglia/macrophage in Inflammation Combined with Ultrasound for Breaking Through the Blood–brain Barrier

Hypoxia-responsive Calixarene-Grafted Self-Assembled Peptide Hydrogel for Inflammation Suppression in Ischemic Stroke

Targeting lipid nanoparticles to the blood brain barrier to ameliorate acute ischemic stroke

The Optimization Design of Macrophage Membrane Camouflaging Liposomes for Alleviating Ischemic Stroke Injury through Intranasal Delivery

Biomimetic Nanocomplexes Orchestrate Post-Stroke Cerebral Microenvironment Via Microglia-Targeted Sirna Delivery

Panax notoginseng saponins and acetylsalicylic acid co-delivered liposomes for targeted treatment of ischemic stroke

Receptors, Channel Proteins, and Enzymes Involved in Microglia-mediated Neuroinflammation and Treatments by Targeting Microglia in Ischemic Stroke

A neurovascular dual-targeting platelet-like bioinspired nanoplatform for ischemic stroke treatment

Dynamically Crosslinked ECM-like Hydrogels Loaded with ROS-responsive Drug Nanoparticles for Treating Inflammation in Myocardial Infarction and Stroke

Remodeling brain pathological microenvironment to lessen cerebral ischemia injury by multifunctional injectable hydrogels